Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial

BACKGROUND: Standard-of-care antiretroviral therapy (ART) uses a combination of drugs deemed essential to minimise treatment failure and drug resistance. Protease inhibitors are potent, with a high genetic barrier to resistance, and have potential use as monotherapy after viral load suppression is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Paton, Nicholas I, Stöhr, Wolfgang, Arenas-Pinto, Alejandro, Fisher, Martin, Williams, Ian, Johnson, Margaret, Orkin, Chloe, Chen, Fabian, Lee, Vincent, Winston, Alan, Gompels, Mark, Fox, Julie, Scott, Karen, Dunn, David T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765553/
https://www.ncbi.nlm.nih.gov/pubmed/26423649
http://dx.doi.org/10.1016/S2352-3018(15)00176-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765553/
https://www.ncbi.nlm.nih.gov/pubmed/26423649
http://dx.doi.org/10.1016/S2352-3018(15)00176-9

Ejemplares similares